Molecular Imaging: Page 113

PET shows promise for detecting NSCLC recurrence

By Kate Madden Yee

F-18 FDG PET/CT shows promise for detecting recurrence of disease in non-small cell lung cancer (NSCLC) patients after they've undergone surgery, according to a study published September 9 in General Thoracic and Cardiovascular Surgery.

September 16, 2020

PET agent shows promise for imaging lung inflammation

By Kate Madden Yee

An experimental PET imaging agent shows promise for imaging inflammation in the lungs -- which could have implications for a range of common diseases, including COVID-19, according to results from an animal study published in Redox Biology.

September 15, 2020

PET helps diagnose treatable form of dementia

By Kate Madden Yee

PET imaging could be a useful tool for diagnosis and treatment of idiopathic normal pressure hydrocephalus, a form of dementia that can be treated surgically, according to a literature review published September 7 in the International Journal of Molecular Sciences.

September 15, 2020

Q BioMed reports sales progress with Strontium89

By AuntMinnie.com staff writers

Biotech company Q BioMed is reporting sales progress from the launch of its Strontium89 (strontium-89 chloride injection) metastatic bone cancer palliation radiopharmaceutical.

September 14, 2020

SNMMI selects Wagner-Torizuka fellowship winners

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has selected the recipients of the 2020-2022 Wagner-Torizuka fellowship.

September 13, 2020

NIH to fund PET imaging for Latino Alzheimer's study

By Theresa Pablos

The U.S. National Institutes of Health (NIH) has provided additional funding for researchers to use PET imaging to study Alzheimer's disease among Mexican Americans. The funds add amyloid and tau PET imaging to the ongoing Health and Aging Brain Among Latino Elders study.

September 13, 2020

FET-PET offers more info on treatment of brain metastases

By Wayne Forrest

Using PET with the radiolabeled amino acid F-18 fluoroethyl tyrosine (F-18 FET) can significantly help determine the efficacy of radiotherapy in certain cancer patients who develop brain metastases, according to a study published online September 4 in the Journal of Nuclear Medicine.

September 13, 2020

FDA grants rare disease designation to Clarity agent

By AuntMinnie.com staff writers

Radiopharmaceutical firm Clarity Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation to its radiopharmaceutical for neuroblastoma.

September 9, 2020

PET radiomics tailor head/neck cancer treatment

By Kate Madden Yee

Radiomic factors -- that is, image-based tumor phenotypes -- gleaned from F-18 FDG PET exams can help clinicians personalize care and better predict treatment outcomes for patients with head and neck squamous cell carcinoma, according to a study published September 7 in EJNMMI Research.

September 9, 2020

UCSD is 1st to get Canon's AI-based MRI

By AuntMinnie.com staff writers

University of California, San Diego (UCSD) Health is the first facility in the U.S. to install a 3-tesla MRI system from Canon Medical Systems USA that includes artificial intelligence-(AI) based reconstruction.

September 8, 2020

RadioMedix, Curium win FDA clearance for Detectnet

By AuntMinnie.com staff writers

Biotechnology firm RadioMedix and global nuclear medicine firm Curium have received U.S. Food and Drug Administration (FDA) clearance for their Detectnet PET diagnostic radiopharmaceutical copper-64 DOTATATE.

September 7, 2020

Isotopia, CPDC ink manufacturing deal for lutetium-177

By AuntMinnie.com staff writers

Isotopia Molecular Imaging of Israel has signed a production agreement for no-carrier-added lutetium-177 with radiopharmaceutical manufacturer Centre for Probe Development and Commercialization (CPDC) of Canada.

September 7, 2020

Previous Page

Page 113 of 614

Next Page